By Nicole Ireland TORONTO — Health Canada has approved Moderna’s mRNA vaccine to protect against respiratory syncytial virus in adults age 60 and older — but it won’t be available until next year, the company said on Friday. In a news release, Moderna said it expects the RSV vaccine _ called mRESVIA — to be […]